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SCIENTIFIC OPINION  
Scientific Opinion on Flavouring Group Evaluation 12, Revision 3 
(FGE.12Rev3): Primary saturated or unsaturated alicyclic alcohol, 
aldehyde, acid, and esters from chemical group 71 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3  
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT  
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European 
Food Safety Authority was requested to evaluate 10 flavouring substances in the Flavouring Group 
Evaluation 12 (FGE.12), including an additional substance in revision 3, using the Procedure in 
Commission Regulation (EC) No 1565/2000. This revision is made due to inclusion of one additional 
flavouring substance, 2,6,6-trimethylcyclohex-2-ene-1-carboxaldehyde [FL-no: 05.182]. None of the 
substances were considered to have genotoxic potential. The substances were evaluated through a 
stepwise approach (the Procedure) that integrates information on structure-activity relationships, 
intake from current uses, toxicological threshold of concern, and available data on metabolism and 
toxicity. The Panel concluded that all 10 substances [FL-no: 02.134, 02.186, 05.157, 05.182, 05.183, 
05.198, 08.135, 09.342, 09.670 and 09.829] do not give rise to safety concerns at their levels of 
dietary intake, estimated on the basis of the MSDI approach. Besides the safety assessment of these 
flavouring substances, the specifications for the materials of commerce have also been considered. 
Specifications including complete purity criteria and identity for the materials of commerce have been 
provided for all 10 candidate substances. 
© European Food Safety Authority, 2012 
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SUMMARY  
The European Food Safety Authority (EFSA) asked the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (the Panel) to provide scientific advice to the Commission on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was requested to evaluate 10 flavouring substances in the 
Flavouring Group Evaluation 12, Revision 3 (FGE.12Rev3), using the Procedure as referred to in the 
Commission Regulation (EC) No 1565/2000. These 10 primary saturated or unsaturated alicyclic 
alcohol, aldehyde, acid and esters belong to chemical group 7, Annex I of the Commission Regulation 
(EC) No 1565/2000. 
The present revision of FGE.12, FGE.12Rev3, includes the assessment of one additional flavouring 
substance, 2,6,6-trimethylcyclohex-2-ene-1-carboxaldehyde [FL-no: 05.182], compared to 
FGE.12Rev2.  
Eight flavouring substances possess one or more chiral centres and additionally, due to the presence of 
a double bond, one of these substances can exist as geometric isomer. For all eight substances, the 
stereoisomeric composition has been specified sufficiently. 
The 10 flavouring substances are classified into structural class I according to the decision tree 
approach presented by Cramer et al., 1978. 
Four of the flavouring substances in the present group have been reported to occur in essential oils and 
in a few food items. 
In its evaluation, the Panel as a default used the Maximised Survey-derived Daily Intake (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe. However, when the 
Panel examined the information provided by the European Flavouring Industry on the use levels in 
various foods, it appeared obvious that the MSDI approach in a number of cases would grossly 
underestimate the intake by regular consumers of products flavoured at the use level reported by the 
Industry, especially in those cases where the annual production values were reported to be small. In 
consequence, the Panel had reservations about the data on use and use levels provided and the intake 
estimates obtained by the MSDI approach.  
In the absence of more precise information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a modified Theoretical Added Maximum Daily Intake 
(mTAMDI) approach based on the normal use levels reported by Industry. In those cases where the 
mTAMDI approach indicated that the intake of a flavouring substance might exceed its corresponding 
threshold of concern, the Panel decided not to carry out a formal safety assessment using the 
Procedure. In these cases the Panel requires more precise data on use and use levels. 
According to the default MSDI approach, the 10 flavouring substances in this group have intakes in 
Europe from 0.011 to 43 microgram/capita/day, which are below the threshold of concern value for 
structural class I (1800 microgram/person/day) substances.  
The genotoxic potential of this group of flavouring substances cannot be assessed since information on 
the flavouring substances or on structurally related substances is missing. However, this does not 
preclude evaluation of the flavouring substances in the present group using the Procedure. 
The flavouring substances are expected to be metabolised to innocuous products at the estimated 
levels of intake as flavouring substances. 
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It is considered that on the basis of the default MSDI approach these 10 flavouring substances would 
not give rise to safety concerns at the estimated levels of intake arising from their use as flavouring 
substances.  
When the estimated intakes were based on the mTAMDI they ranged from 2 to 5000 
microgram/person/day for the 10 flavouring substances from structural class I. For six of the 
substances the intakes were above the threshold of concern for structural class I of 1800 
microgram/person/day. Thus, for six flavouring substances considered in this Opinion, the intakes, 
estimated on the basis of the mTAMDI, exceed the relevant threshold for their structural class to 
which the flavouring substance has been assigned. Therefore, for these six substances [FL-no: 02.134, 
02.186, 08.135, 09.342, 09.670 and 09.829] more reliable exposure data are required. On the basis of 
such additional data, these flavouring substances should be reconsidered along the steps of the 
Procedure. Following this procedure, additional toxicological data might become necessary. The four 
substances which have mTAMDI intake estimates below the threshold of concern for structural class I 
are also expected to be metabolised to innocuous products. 
In order to determine whether this evaluation could be applied to the material of commerce, it is 
necessary to consider the available specifications. Specifications including complete purity criteria and 
identity tests for the materials of commerce have been provided for each of the 10 flavouring 
substances.  
For these 10 flavouring substances [FL-no: 02.134, 02.186, 05.157, 05.182, 05.183, 05.198, 08.135, 
09.342, 09.670 and 09.829], the Panel concluded that they would present no safety concern at the 
estimated levels of intake based on the MSDI approach. 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 
2002b).  
The FGE is revised to include substances for which data were submitted after the deadline as laid 
down in Commission Regulation (EC) No 622/2002 and to take into account additional information 
that has been made available since the previous Opinion on this FGE.  
The Union list of flavourings and source materials is established in Commission Regulation (EC) No 
872/2012 (EC, 2012a). 
HISTORY OF THE EVALUATION  
The first version of the Flavouring Group Evaluation 12 (FGE.12) dealt with four primary saturated or 
unsaturated alicyclic alcohol, aldehyde, acid and esters. 
The first Revision of FGE.12 (FGE.12Rev1) included the assessment of three additional candidate 
substances [FL-no: 02.134, 05.137 and 05.198]. Additional information on two substances [FL-no: 
05.183 and 09.342] was made available since FGE.12 was published. 
The second Revision of FGE.12, FGE.12Rev2, includes the assessment of two additional candidate 
substances [FL-no: 08.135 and 09.829]. No toxicity and/or metabolism data were provided for these 
substances. Furthermore, for four substances [FL-no: 02.186, 05.157, 05.198 and 09.670], information 
from Industry (EFFA, 2010a) on stereoisomeric composition and missing specifications, received after 
publication of the last revision, was included in Revision 2. 
FGE Opinion adopted 
by EFSA 
Link No. of 
candidate 
substances 
FGE.12 23 February 2005 http://www.efsa.europa.eu/en/scdocs/scdoc/208.htm 4 
FGE.12Rev
1 
28 August 2008 http://www.efsa.europa.eu/en/scdocs/scdoc/791.htm 7 
FGE.12Rev
2 
30 September 2010 http://www.efsa.europa.eu/en/efsajournal/doc/1846.pdf 9 
FGE.12Rev
3 
20 Novembre 2012  10 
 
The present Revision of FGE.12, FGE.12Rev3, includes the assessment of one additional candidate 
substance, 2,6,6-trimethylcyclohex-2-ene-1-carboxaldehyde [FL-no: 05.182]. No toxicity or 
metabolism data were provided for the substance. A search in open literature did not provide any 
further data on toxicity or metabolism for the substance. 
Flavouring Group Evaluation 12, Revision 3 
 
 
6 EFSA Journal 2012;10(12):2993 
Furthermore, additional information on stereoisomeric composition has been submitted for four 
substances [FL-no: 02.186, 05.157, 05.198 and 09.670] (EFFA, 2012v). 
TERMS OF REFERENCE AS PROVIDED BY THE COMMISSION 
The European Food Safety Authority (EFSA) is requested to carry out a risk assessment on flavouring 
substances in the Register prior to their authorisation and inclusion in the Union List according to 
Commission Regulation (EC) No 1565/2000 (EC, 2000a). In addition, the Commission requested 
EFSA to evaluate newly notified flavouring substances, where possible, before finalising the 
evaluation programme. The evaluation programme was finalised at the end of 2009. 
In addition, the Commission has asked EFSA to reflect newly submitted information on specifications 
in the revisions of FGEs. 
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ASSESSMENT 
1. Presentation of the Substances in Flavouring Group Evaluation 12, Revision 3 
1.1. Description 
The present Flavouring Group Evaluation 12, Revision 3 (FGE.12Rev3), using the Procedure as 
referred to in the Commission Regulation (EC) No 1565/2000 (EC, 2000a) (The Procedure – shown in 
schematic form in Annex I), deals with 10 candidate substances from chemical group 7, Annex I of 
Commission Regulation (EC) No 1565/2000 (EC, 2000a).  
The 10 flavouring substances under consideration, as well as their chemical Register names, FLAVIS- 
(FL-), Chemical Abstract Service- (CAS-), Council of Europe- (CoE-) and Flavor and Extract 
Manufacturers Association- (FEMA-) numbers, structure and specifications, are listed in Table 1.  
Out of the 10 substances, one is a primary saturated alicyclic acid [FL-no: 08.135], three are esters, 
two [FL-no: 09.342 and 09.670] with a primary saturated or unsaturated alicyclic alcohol moiety and 
one [FL-no: 09.829] is an ethyl ester of a saturated alicyclic carboxylic acid, two substances [FL-no: 
02.134 and 02.186] are primary alicyclic saturated alcohols and four are alicyclic unsaturated 
aldehydes [FL-no: 05.157, 05.182, 05.183 and 05.198]. 
A summary of the safety evaluation is summarised in Table 2a. 
The 10 flavouring substances (candidate substances) are related structurally to 15 flavouring 
substances (supporting substances) evaluated at the 59th JECFA meeting as “Alicyclic Primary 
Alcohols, Aldehydes, Acids, and Related Esters” (JECFA, 2003a). The supporting substances, with 
the respective structural formulas, FEMA, CoE, and CAS register numbers, evaluation status by 
Scientific committee on Food (SCF), JECFA, and by CoE and the European Maximised Survey-
derived Daily Intake (MSDI) values, are listed in Table 3. 
The hydrolysis products of the candidate esters are listed in Table 2b. 
1.2. Stereoisomers 
It is recognised that geometrical and optical isomers of substances may have different properties. Their 
flavour may be different, they may have different chemical properties resulting in possible variability 
in their absorption, distribution, metabolism, elimination and toxicity. Thus, information must be 
provided on the configuration of the flavouring substance, i.e. whether it is one of the 
geometrical/optical isomers, or a defined mixture of stereoisomers. The available specifications of 
purity will be considered in order to determine whether the safety evaluation carried out for candidate 
substances for which stereoisomers may exist can be applied to the material of commerce. Flavouring 
substances with different configurations should have individual chemical names and codes (CAS 
number, FLAVIS number etc.). 
Eight of the 10 flavouring substances possess one or more chiral centres and additionally, due to the 
presence of a double bond, one of these substances [FL-no: 05.198] can exist as geometric isomer. The 
stereoisomeric composition has been specified for all eight substances (see Table 1). 
1.3. Natural Occurrence in Food 
Three of the 10 candidate substances 2-cyclohexylethan-1-ol [FL-no: 02.134], myrtanol [FL-no: 
02.186] and myrtanyl acetate [FL-no: 09.670] have been reported to occur in essential oils. One 
Flavouring Group Evaluation 12, Revision 3 
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substance, 2,6,6-trimethylcyclohex-2-ene-1-carboxaldehyde [FL-no: 05.182], has been reported to 
occur naturally in grape brandy and tomato (TNO, 2012). No quantitative data were reported. 
According to TNO, six of the substances isocyclocitral [FL-no: 05.157], 4-(2,6,6-
trimethylcyclohexenyl)-2-methylbutanal [FL-no: 05.183], alpha-methyl ional [FL-no: 05.198], 4-
(2,2,3-trimethylcyclopentyl)butanoic acid [FL-no: 08.135], cyclogeranyl acetate [FL-no: 09.342] and 
ethyl cyclohexyl acetate [FL-no: 09.829] have not been reported to occur naturally in any food items 
(TNO, 2000; TNO, 2009). 
2. Specifications 
Purity criteria for the 10 candidate substances have been provided by the Flavouring Industry (EFFA, 
2003i; EFFA, 2004z; Flavour Industry, 2009i). 
Judged against the requirements in Annex II of Commission Regulation (EC) No 1565/2000 (EC, 
2000a), the information is adequate for all 10 candidate substances (see Section 1.2 and Table 1). 
3. Intake Data 
Annual production volumes of the flavouring substances as surveyed by the Industry can be used to 
calculate the “Maximised Survey-derived Daily Intake” (MSDI) by assuming that the production 
figure only represents 60 % of the use in food due to underreporting and that 10 % of the total EU 
population are consumers (SCF, 1999a). 
However, the Panel noted that due to year-to-year variability in production volumes, to uncertainties 
in the underreporting correction factor and to uncertainties in the percentage of consumers, the 
reliability of intake estimates on the basis of the MSDI approach is difficult to assess. 
The Panel also noted that in contrast to the generally low per capita intake figures estimated on the 
basis of this MSDI approach, in some cases the regular consumption of products flavoured at use 
levels reported by the Flavour Industry in the submissions would result in much higher intakes. In 
such cases, the human exposure thresholds below which exposures are not considered to present a 
safety concern might be exceeded. 
Considering that the MSDI model may underestimate the intake of flavouring substances by certain 
groups of consumers, the SCF recommended also taking into account the results of other intake 
assessments (SCF, 1999a). 
One of the alternatives is the “Theoretical Added Maximum Daily Intake” (TAMDI) approach, which 
is calculated on the basis of standard portions and upper use levels (SCF, 1995) for flavourable 
beverages and foods in general, with exceptional levels for particular foods. This method is regarded 
as a conservative estimate of the actual intake by most consumers because it is based on the 
assumption that the consumer regularly eats and drinks several food products containing the same 
flavouring substance at the upper use level. 
One option to modify the TAMDI approach is to base the calculation on normal rather than upper use 
levels of the flavouring substances. This modified approach is less conservative (e.g., it may 
underestimate the intake of consumers being loyal to products flavoured at the maximum use levels 
reported) (EC, 2000a). However, it is considered as a suitable tool to screen and prioritise the 
flavouring substances according to the need for refined intake data (EFSA, 2004a). 
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3.1. Estimated Daily per Capita Intake (MSDI Approach) 
The intake estimation is based on the Maximised Survey-derived Daily Intake (MSDI) approach, 
which involves the acquisition of data on the amounts used in food as flavourings (SCF, 1999a). These 
data are derived from surveys on annual production volumes in Europe. These surveys were conducted 
in 1995 by the International Organization of the Flavour Industry (IOFI), in which flavour 
manufacturers reported the total amount of each flavouring substance incorporated into food sold in 
the EU during the previous year (IOFI, 1995a). The intake approach does not consider the possible 
natural occurrence in food. 
Average per capita intake (MSDI) is estimated on the assumption that the amount added to food is 
consumed by 10 % of the population4 (Eurostat, 1998). This is derived for candidate substances from 
estimates of annual volume of production provided by Industry and incorporates a correction factor of 
0.6 to allow for incomplete reporting (60 %) in the Industry surveys (SCF, 1999a). 
In the present Flavouring Group Evaluation (FGE.12Rev3) the total annual volume of production of 
the 10 candidate substances for use as flavouring substances in Europe has been reported to be 
approximately 370 kg (EFFA, 2003i; EFFA, 2004z; EFFA, 2007a; EFFA, 2011e; Flavour Industry, 
2009i). Three hundred fifty kg of this amount is accounted for by one of these flavouring substances, 
4-(2,2,3-trimethylcyclopentyl)butanoic acid [FL-no: 08.135]. For the 15 supporting substances the 
total annual volume of production is approximately 370 kg (JECFA, 2003a). 
On the basis of the annual volumes of production reported for the 10 candidate substances, the daily 
per capita intakes for each of these flavourings have been estimated (Table 2a).  
The estimated daily per capita intake of 4-(2,2,3-trimethylcyclopentyl)butanoic acid [FL-no: 08.135] 
from use as a flavouring substance is 43 microgram. For the remaining substances, the estimated daily 
per capita intake is less than 1 microgram each (Table 2a). 
3.2. Intake Estimated on the Basis of the Modified TAMDI (mTAMDI) 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values 
is based on the approach used by SCF up to 1995 (SCF, 1995). 
The assumption is that a person may consume a certain amount of flavourable foods and beverages per 
day. 
For the 10 candidate substances information on food categories and normal and maximum use 
levels5,6,7 were submitted by the Flavour Industry (EFFA, 2003i; EFFA, 2004z; EFFA, 2007a; EFFA, 
2012q; Flavour Industry, 2009i).  
The 10 candidate substances are used in flavoured food products divided into the food categories, 
outlined in Annex III of the Commission Regulation 1565/2000 (EC, 2000a), as shown in Table 3.1. 
For the present calculation of mTAMDI, the reported normal use levels were used. In the case where 
different use levels were reported for different food categories the highest reported normal use level 
was used. 
                                                     
 
4 EU figure 375 millions. This figure relates to EU population at the time for which production data are available, and is consistent (comparable) with 
evaluations conducted prior to the enlargement of the EU. No production data are available for the enlarged EU. 
5 ”Normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th percentile of reported usages (EFFA, 2002i). 
6 The normal and maximum use levels in different food categories (EC, 2000) have been extrapolated from figures derived from 12 model flavouring substances 
(EFFA, 2004e). 
7 The use levels from food category 5 “Confectionery” have been inserted as default values for food category 14.2 “Alcoholic beverages” for substances for 
which no data have been given for food category 14.2 (EFFA, 2007a). 
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Table 3.1 Use of Candidate Substances in Various Food Categories 
Food 
category 
Description Flavourings used 
01.0 Dairy products, excluding products of category 2 All except [FL-no: 
05.182] 
02.0 Fats and oils, and fat emulsions (type water-in-oil) All except [FL-no: 
05.182, 08.135] 
03.0 Edible ices, including sherbet and sorbet All except [FL-no: 
08.135] 
04.1 Processed fruits All except [FL-no: 
08.135] 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and 
legumes), and nuts & seeds 
None 
05.0 Confectionery All 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses 
& legumes, excluding bakery 
All except [FL-no: 
05.182, 08.135] 
07.0 Bakery wares All except [FL-no: 
08.135] 
08.0 Meat and meat products, including poultry and game All except [FL-no: 
05.182, 08.135] 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  All except [FL-no: 
05.182, 08.135] 
10.0 Eggs and egg products None 
11.0 Sweeteners, including honey Only [FL-no: 08.135] 
12.0 Salts, spices, soups, sauces, salads, protein products etc. All except [FL-no: 
05.182, 08.135] 
13.0 Foodstuffs intended for particular nutritional uses All except [FL-no: 
05.182, 08.135] 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products All 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts All except [FL-no: 
05.182] 
15.0 Ready-to-eat savouries All except [FL-no: 
05.182, 08.135] 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not 
be placed in categories 1 – 15 
All except [FL-no: 
05.182] 
 
According to the Flavour Industry the normal use levels for the candidate substances are in the range 
of 0.002 - 20 mg/kg food, and the maximum use levels are in the range of 0.02 - 100 mg/kg (EFFA, 
2003i; EFFA, 2004z; EFFA, 2007a; EFFA, 2012q; Flavour Industry, 2009i).  
The mTAMDI values for the 10 candidate substances from structural class I (see Section 5) range 
from 2 to 5000 microgram/person/day. 
For detailed information on use levels and intake estimations based on the mTAMDI approach, see 
Section 6 and Annex II. 
4. Absorption, Distribution, Metabolism and Elimination 
All 10 candidate substances in this group evaluation contain a monocyclic or bicyclic alicyclic moiety 
with substituents containing a primary alcohol, aldehyde, carboxylic acid or ester function. The 
evaluation of the metabolism and other aspects of kinetics of the candidate substances in this 
Flavouring Group Evaluation depend entirely on information for structurally related substances (see 
Table 3 and Annex III) and on general knowledge on biochemistry and biotransformation of 
xenobiotic substances. 
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It is expected that the three esters in this group will be hydrolysed to yield their component alcohols 
and carboxylic acids. It is also anticipated that these hydrolysis products may be absorbed and that any 
remaining unhydrolysed flavouring esters, after absorption, will be hydrolysed in the liver. Gastro-
intestinal absorption can also be expected for the alcohols, carboxylic acids and the aldehydes in the 
present group. 
The metabolic fate of the three component alcohols, the two candidate alcohols and the four aldehydes 
in this Flavouring Group is not completely elucidated. It can be expected that oxidation of the 
hydroxyl group or aldehyde group will result in the formation of carboxylic acids which can be 
conjugated and excreted. Alternatively, the component or free alcohols in this group may be 
conjugated to glucuronide or sulphate without any further oxidation. Further, the cyclohexene 
derivatives may undergo allylic hydroxylation of the ring and then possible oxidation to keto groups 
or conjugation with glucuronic acid. These polar metabolites are expected to be excreted in the urine. 
One substance [FL-no: 05.198] has a double bond in the side chain. This is not anticipated to alter the 
major metabolic pathways outlined above. 
Neither the chemical structures of the candidate substances in this group nor the metabolic data 
available suggest that reactive metabolites could be generated. Hence, it may be expected that the 
candidate substances in this flavouring group are absorbed and metabolised to innocuous products, 
which are excreted. 
For more detailed information, see Annex III. 
5. Application of the Procedure for the Safety Evaluation of Flavouring Substances 
The application of the Procedure is based on intakes estimated on the basis of the MSDI approach. 
Where the mTAMDI approach indicates that the intake of a flavouring substance might exceed its 
corresponding threshold of concern, a formal safety assessment is not carried out using the Procedure. 
In these cases the Panel requires more precise data on use and use levels. For comparison of the intake 
estimations based on the MSDI approach and the mTAMDI approach, see Section 6. 
For the safety evaluation of the 10 candidate substances from chemical group 7 the Procedure as 
outlined in Annex I was applied, based on the MSDI approach. The stepwise evaluations of the 
substances are summarised in Table 2a. 
Step 1 
All 10 candidate substances are classified into structural class I according to the decision tree approach 
presented by Cramer et al. (Cramer et al., 1978). 
Step 2 
It is anticipated that the three esters in this group will be hydrolysed to yield their component alcohols 
and carboxylic acids, and that the component alcohols and carboxylic acids as well as the two 
candidate alcohols, the four aldehydes and the carboxylic acid will be metabolised to innocuous 
products at the estimated levels of intake and accordingly proceed via the A-side of the Procedure.  
Step A3 
The 10 candidate substances, which have all been assigned to structural class I, have estimated 
European daily per capita intakes from use as flavouring substances ranging from 0.011 to 43 
microgram. These estimated intakes are below the threshold of concern of 1800 microgram/person/day 
for structural class I.  
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The substances would accordingly not be expected to be of safety concern at their estimated levels of 
intake based on the MSDI approach. 
6. Comparison of the Intake Estimations Based on the MSDI Approach and the mTAMDI 
Approach 
The MSDI range from 0.011 to 43 microgram/capita/day. These figures are below the threshold of 
concern value for substances belonging to structural class I (1800 microgram/person/day). 
The estimated intakes for the 10 candidate substances in structural class I based on the mTAMDI 
range from 2 to 5000 microgram/person/day. For four of the substances [FL-no: 05.157, 05.182, 
05.183 and 05.198], the mTAMDI is below the threshold of concern of 1800 microgram/person/day. 
For six candidate substances [FL-no: 02.134, 02.186, 08.135, 09.342, 09.670 and 09.829], the 
mTAMDI is exceeding the threshold of concern.  
Thus, for six substances [FL-no: 02.134, 02.186, 08.135, 09.342, 09.670 and 09.829] further 
information is required. This would include more reliable intake data and then, if required, additional 
toxicological data. 
For comparison of the intake estimates based on the MSDI approach and the mTAMDI approach, see 
Table 6.1.  
 
Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI 
(g/capita/day) 
mTAMDI 
(g/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
02.134 2-Cyclohexylethan-1-ol 0.011 3900 Class I 1800 
02.186 Myrtanol 0.37 3900 Class I 1800 
05.157 Isocyclocitral 0.011 1600 Class I 1800 
05.182 2,6,6-Trimethylcyclohex-2-ene-1-
carboxaldehyde 
0.061 2.1 Class I 1800 
05.183 4-(2,6,6-Trimethylcyclohexenyl)-2-
methylbutanal 
0.012 1600 Class I 1800 
05.198 alpha-Methyl ional 0.011 1600 Class I 1800 
08.135 4-(2,2,3-Trimethylcyclopentyl)butanoic acid 43 5000 Class I 1800 
09.342 Cyclogeranyl acetate 0.24 3900 Class I 1800 
09.670 Myrtanyl acetate 0.58 3900 Class I 1800 
09.829 Ethyl cyclohexyl acetate 0.61 3900 Class I 1800 
7. Considerations of Combined Intakes from Use as Flavouring Substances 
Because of structural similarities of candidate and supporting substances, it can be anticipated that 
many of the flavourings are metabolised through the same metabolic pathways and that the 
metabolites may affect the same target organs. Further, in case of combined exposure to structurally 
related flavourings, the pathways could be overloaded. Therefore, combined intake should be 
considered. As flavourings not included in this FGE may also be metabolised through the same 
pathways, the combined intake estimates presented here are only preliminary. Currently, the combined 
intake estimates are only based on MSDI exposure estimates, although it is recognised that this may 
lead to underestimation of exposure. After completion of all FGEs, this issue should be readdressed. 
The total estimated combined daily per capita intake of structurally related flavourings is estimated by 
summing the MSDI for individual substances. 
On the basis of the reported annual production volumes in Europe (EFFA, 2003i; EFFA, 2004z; 
EFFA, 2007a; EFFA, 2011e; Flavour Industry, 2009i), the combined estimated daily per capita intake 
as flavourings of the 10 candidate flavouring substances assigned to structural class I is 45 microgram, 
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which does not exceed the threshold of concern for a compound belonging to structural class I of 1800 
microgram/person/day.  
The 10 candidate substances are structurally related to 15 supporting substances evaluated by the 
JEFCA at its 59th meeting (JECFA, 2003a). The estimated combined intake (in Europe) is 
approximately 41 microgram/capita/day for the 15 of the supporting substances assigned to structural 
class I. The total estimated combined intake of candidate and supporting substances (in Europe) would 
be approximately 86 microgram, which does not exceed the threshold of concern for the 
corresponding structural class I (1800 microgram/person/day). 
8. Toxicity 
8.1. Acute Toxicity 
Studies were available for three of the 10 candidate substances and for nine supporting substances. 
The oral LD50 in rats range from 890 to 5270 mg/kg body weight (bw).  
The acute toxicity data are summarised in Annex IV, Table IV.1. 
8.2. Subacute, Subchronic, Chronic and Carcinogenicity Studies 
No studies were available for any of the 10 candidate substances.  
There was one study available for the supporting substance 2,2,3-trimethylcyclopent-3-en-1-yl 
acetaldehyde [FL-no: 05.119]. This is a single dose level, 90 days gavage study. The oral dose of 12 
mg/kg bw/day to rats did not induce adverse effects in this study. 
There are no carcinogenicity studies to be found neither for the 10 candidate substances nor for any of 
the 15 supporting substances.  
Repeated dose toxicity data are summarised in Annex IV, Table IV.2. 
8.3. Developmental / Reproductive Toxicity Studies 
There are no studies available on developmental or reproductive toxicity neither for the 10 candidate 
substances nor for the 15 supporting substances. 
8.4. Genotoxicity Studies 
There are no studies available on genotoxicity neither for the 10 candidate nor for the 15 supporting 
substances. The genotoxic potential of this group of flavouring substances can therefore not be 
assessed properly. However, this does not preclude evaluation of the candidate substances in the 
present group using the Procedure (SCF, 1999a). 
CONCLUSIONS 
The present Revision of FGE.12, FGE.12Rev3, includes the assessment of one additional candidate 
substance, 2,6,6-trimethylcyclohex-2-ene-1-carboxaldehyde [FL-no: 05.182], compared to 
FGE.12Rev2. 
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Out of the total 10 substances, one is an alicyclic saturated acid, two are primary alicyclic saturated 
alcohols, four are alicyclic unsaturated aldehydes and three are esters, two with a primary saturated or 
unsaturated alicyclic alcohol moiety and one is an ethyl ester of a saturated alicyclic carboxylic acid. 
Eight of the 10 flavouring substances possess one or more chiral centres and additionally, due to the 
presence of a double bond, one of these substances can exist as geometric isomer. For all eight 
substances, the stereoisomeric composition has been specified sufficiently. 
All of the 10 candidate substances belong to structural class I according to the decision tree approach 
presented by Cramer et al., 1978.  
Four of the flavouring substances in the present group have been reported to occur naturally in 
essential oils and in a few foods. 
According to the default MSDI approach, the 10 candidate substances in this group have estimated 
European daily per capita intakes from use as flavouring substances ranging from 0.011 microgram to 
43 microgram. These estimated intakes are below the threshold of concern of 1800 
microgram/person/day for structural class I. 
On the basis of the reported annual production in Europe (MSDI approach), the combined intake of 
the 10 candidate substances, belonging to structural class I, would result in a total intake of 45 
microgram/capita/day. This value is below the threshold of concern for structural class I. The total 
combined intakes of the 15 supporting substances and the 10 candidate substances is approximately 86 
microgram/capita/day, which is below the threshold of concern for structural class I (1800 
microgram/person/day).  
The genotoxic potential of this group of flavouring substances cannot be assessed since information on 
the candidate and supporting substances is missing. However, this does not preclude evaluation of the 
flavouring substances in the present group using the Procedure. 
The 10 candidate substances are expected to be absorbed and metabolised to innocuous products, 
which will subsequently be excreted. The esters are expected to be hydrolysed to component alcohols 
and carboxylic acids, and the acids subsequently either oxidised completely or conjugated and 
excreted. The component alcohols, the candidate alcohols, and the candidate aldehydes are expected to 
be oxidised to carboxylic acids, conjugated and excreted. The candidate substances, which are 
cyclohexene derivatives, may also undergo allylic ring hydroxylation and possible further oxidation or 
conjugation before excretion. Neither the chemical structures of the candidate substances in this group 
nor the metabolic data available suggest that reactive metabolites could be generated. 
No valid toxicity studies have been provided for any of the candidate substances and only one 
adequate subchronic study was available on a supporting substance. 
It is considered that on the basis of the default MSDI approach the 10 candidate substances would not 
give rise to safety concerns at the estimated levels of intake arising from their use as flavouring 
substances.  
When the estimated intakes were based on the mTAMDI they ranged from 2 to 5000 
microgram/person/day for the 10 flavouring substances from structural class I. The intakes were above 
the threshold of concern for structural class I of 1800 microgram/person/day for six flavouring 
substances [FL-no: 02.134, 02.186, 08.135, 09.342, 09.670 and 09.829] and below the threshold for 
four flavouring substances [FL-no: 05.157, 05.182, 05.183 and 05.198]. Thus, for six of the 10 
flavouring substances considered in this Opinion the intakes, estimated on the basis of the mTAMDI, 
exceed the relevant threshold for their structural class, to which the flavouring substance has been 
assigned. Therefore, for these six substances more reliable exposure data are required. On the basis of 
such additional data, these flavouring substances should be reconsidered along the steps of the 
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Procedure. Following this Procedure, additional toxicological data might become necessary. The four 
substances, which have mTAMDI intake estimates below the threshold of concern for structural class I 
are also expected to be metabolised to innocuous products. 
In order to determine whether the conclusion for the 10 candidate substances can be applied to the 
material of commerce, it is necessary to consider the available specifications. Specifications including 
complete purity criteria and identity for the materials of commerce have been provided for each of the 
10 flavouring substances.  
For these 10 flavouring substances [FL-no: 02.134, 02.186, 05.157, 05.182, 05.183, 05.198, 08.135, 
09.342, 09.670 and 09.829], the Panel concluded that they would present no safety concern at the 
estimated levels of intake based on the MSDI approach. 
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Table 1:  Specification Summary of the Substances in the Flavouring Group Evaluation 12, Revision 3 
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 12, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 
4) 
Spec.gravity 5) 
Specification comments 
02.134 
 
2-Cyclohexylethan-1-ol OH  
 
4442-79-9 
Liquid 
C8H16O 
128.21 
Slightly soluble 
Freely soluble 
222 
 
MS 
95 % 
1.463-1.469 
0.918-0.924 
 
 
02.186 
 
Myrtanol    
OH
 
 
 
514-99-8 
Solid 
C10H18O 
154.25 
Practically insoluble 
or insoluble 
Freely soluble 
116 (16 hPa) 
77 
MS 
95 % 
n.a. 
n.a. 
 
Mixture of four 
diastereoisomers (EFFA, 
2010a).  
Four diastereoisomers, 20 - 30 
% each,  with a higher 
likelyhood for the trans forms 
(EFFA, 2012v). 
05.157 
 
Isocyclocitral    
O
 
 
 
1335-66-6 
Liquid 
C10H16O 
152.23 
Practically insoluble 
or insoluble 
Freely soluble 
214 
-55 
MS 
95 % 
1.484-1.490 
0.885-0.891 
 
Mixture of two positional 
isomers (95 % sum of isomers, 
mainly 2,4,6-trimethyl-
cyclohex-3-ene-1-carbaldehyde) 
(EFFA, 2010a). CASrn in 
Register refers to "Incomplet 
defined structure" (positions of 
two methyl groups not 
assigned). 
Mixture of 8 diastereoisomers 
(approximately 12.5 % each) 
(EFFA, 2012v). 
05.182 
 
2,6,6-Trimethylcyclohex-2-ene-1-
carboxaldehyde    
O
3639 
10326 
432-24-6 
Liquid 
C10H16O 
152.23 
Insoluble 
Soluble 
62 (0.4 hPa) 
 
MS 
99 % 
1.476-1.483 
0.950-0.957 
 
Racemate (EFFA, 2012v). 
05.183 
 
4-(2,6,6-Trimethylcyclohexenyl)-2-
methylbutanal O
 
 
65405-84-7 
Liquid 
C14H24O 
210.36 
Practically insoluble 
or insoluble 
Freely soluble 
305 
 
MS 
95 % 
1.468-1.474 
0.924-0.930 
 
Racemate. CASrn in Register to 
be changed to 73398-85-3. 
New CASrn refers to the 
racemate. 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 12, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 
4) 
Spec.gravity 5) 
Specification comments 
05.198 
 
alpha-Methyl ional    
O
 
 
 
58102-02-6 
Liquid 
C14H22O 
206.33 
Practically insoluble 
or insoluble 
Freely soluble 
90 (0.1 hPa) 
 
MS 
95 % 
1.485-1.491 
0.911-0.917 
 
Mixture of (Z)- & (E)-isomers. 
Name to be changed to 3-
Butenal, 2-methyl-4-(2,6,6-
trimethyl-2-cyclohexen-1-yl) 
(EFFA, 2010a). E-form (60 - 90 
%); Z-form (10 - 40 %). In each 
case racemate (EFFA, 2012v). 
08.135 
 
4-(2,2,3-
Trimethylcyclopentyl)butanoic acid 
OH
O  
4529 
 
957136-80-0 
Liquid 
C12H22O2 
198 
Slightly soluble 
Partially soluble 
140 - 143 
 
NMR MS 
99 % 
1.461-1.467 
0.955-0.961 
 
Composition of mixture: 50 - 60 
% 4-((1S,3R)-2,2,3-
trimethylcyclopentyl)butanoic 
acid;  
32 - 40 % 4-((1R,3S)- ;   
0 - 6 % 4-((1S,3S)- ;  
0 - 4 % 4-((1R,3R)-  
 
09.342 
 
Cyclogeranyl acetate 
O
O  
 
54993-30-5 
Liquid 
C12H20O2 
196.29 
Practically insoluble 
or insoluble 
Freely soluble  
98 (13 hPa) 
 
MS 
95 % 
1.464-1.470 
0.958-0.964 
 
Racemate. CASrn in Register to 
be changed to 69842-11-1. 
New CASrn refers to the 
racemate. 
09.670 
 
Myrtanyl acetate    
O
O
 
 
 
29021-36-1 
Liquid 
C12H20O2 
196.29 
Practically insoluble 
or insoluble 
Freely soluble 
106 (9 hPa) 
 
MS 
95 % 
1.470-1.476 
0.969-0.975 
 
Mixture of R,S-enantiomers, i.e. 
the (+)- and (-)- (cis)- and 
(trans)-isomers, mixture of all 
diastereoisomers (EFFA, 
2010a).  Four diastereoisomers, 
20 - 30 % each,  with a higher 
likelyhood for the trans forms. 
(EFFA, 2012v). 
09.829 
 
Ethyl cyclohexyl acetate O
O
2348 
218 
5452-75-5 
Liquid 
C10H18O2 
170.25 
Practically insoluble 
or insoluble 
Freely soluble 
211 
 
NMR MS 
95 % 
1.442-1.450 
0.945-0.948 
 
 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 %  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
6) Stereoisomeric composition not specified. 
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Table 2a:  Summary of Safety Evaluation Applying the Procedure (Based on Intakes Calculated by the MSDI Approach) 
Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(g/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
02.134 
 
2-Cyclohexylethan-1-ol OH 0.011 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.186 
 
Myrtanol 
OH
0.37 
 
Class I 
A3: Intake below threshold 
4) 6)  
05.157 
 
Isocyclocitral 
O
0.011 
 
Class I 
A3: Intake below threshold 
4) 6)  
05.182 
 
2,6,6-Trimethylcyclohex-2-ene-
1-carboxaldehyde 
O
0.061 
 
Class I 
A3: Intake below threshold 
4) 6)  
05.183 
 
4-(2,6,6-
Trimethylcyclohexenyl)-2-
methylbutanal 
O
0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
05.198 
 
alpha-Methyl ional 
O
0.011 
 
Class I 
A3: Intake below threshold 
4) 6)  
08.135 
 
4-(2,2,3-
Trimethylcyclopentyl)butanoic 
acid OH
O
43 
 
Class I 
A3: Intake below threshold 
4) 6)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(g/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
09.342 
 
Cyclogeranyl acetate 
O
O 0.24 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.670 
 
Myrtanyl acetate 
O
O
0.58 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.829 
 
Ethyl cyclohexyl acetate O
O
0.61 
 
Class I 
A3: Intake below threshold 
4) 6)  
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
6) No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
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Table 2b:  Evaluation Status of Hydrolysis Products of Candidate Esters  
Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
 Cyclogeraniol 
OH
Not evaluated as flavouring substance  Not in EU-Register. 
02.078 Ethanol 
41 OH  
Category 1 a) 
No safety concern b) 
 
 
 
No evaluation 
At the forty-sixth JECFA meeting (JECFA, 
1997a), the Committee concluded that 
ethanol posed no safety concern at its 
current level of intake when ethyl esters are 
used as flavouring agents. 
02.186 Myrtanol 
 
OH
 
 
 
FGE.12 
Class I 
A3: Intake below threshold 
 
08.002 Acetic acid 
81 
O
OH  
Category 1 a) 
No safety concern c) 
Category A d) 
 
Class I 
A3: Intake above threshold,  
A4: Endogenous 
 
08.034 Cyclohexylacetic acid 
965 
O
OH  
No safety concern e) 
Category B d) 
 
Class I 
A3: Intake below threshold 
 
1) Category 1: Considered safe in use   Category 2: Temporarily considered safe in use   Category 3: Insufficient data to provide assurance of safety in use   Category 4): Not acceptable due to evidence of toxicity. 
2) No safety concern at estimated levels of intake. 
3) Category A: Flavouring substance, which may be used in foodstuffs Category B: Flavouring substance which can be used provisionally in foodstuffs. 
4) Threshold of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
5) Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot. 
a) (SCF, 1995). 
b) (JECFA, 1997a). 
c) (JECFA, 1999b). 
d) (CoE, 1992). 
e) (JECFA, 2002c). 
ND: Not detected. 
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Table 3:  Supporting Substances Summary 
Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(g/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
02.114 2-(2,2,3-Trimethylcyclopent-3-
enyl)ethan-1-ol 
OH
3741 
 
1901-38-8 
970 
JECFA specification (JECFA, 
2002d). 
0.012  
No safety concern a) 
 
 
02.141 2-(6,6-
Dimethylbicyclo[3.1.1]hept-2-
en-2-yl)ethan-1-ol 
OH
3938 
 
128-50-7 
986 
JECFA specification (JECFA, 
2002d). 
33  
No safety concern a) 
 
 
05.098 p-Menth-1-en-9-al 
O
3178 
10347 
29548-14-9 
971 
JECFA specification (JECFA, 
2002d). 
0.12  
No safety concern a) 
 
 
05.112 2,6,6-Trimethylcyclohex-1-en-
1-acetaldehyde 
O
3474 
10338 
472-66-2 
978 
JECFA specification (JECFA, 
2002d). 
0.24  
No safety concern a) 
 
 
05.119 2,2,3-Trimethylcyclopent-3-
en-1-yl acetaldehyde 
O
3592 
10325 
4501-58-0 
967 
JECFA specification (JECFA, 
2002d). 
5.0  
No safety concern a) 
 
 
05.123 5-Isopropenyl-2-
methylcyclopentanecarboxalde
hyde O
3645 
 
55253-28-6 
968 
JECFA specification (JECFA, 
2002d). 
0.012  
No safety concern a) 
 
JECFA evaluated cis-5-
isopropenyl-cis-
methylcyclopentan-1-
carboxaldehyde (CASrn 
as in Register). CASrn 
in Register refers to the 
(Z,Z)-isomer. 
08.034 Cyclohexylacetic acid 
O
OH 2347 
34 
5292-21-7 
965 
JECFA specification (JECFA, 
2002d). 
0.12  
No safety concern a) 
Category B b) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(g/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
08.060 Cyclohexanecarboxylic acid 
OH
O 3531 
11911 
98-89-5 
961 
JECFA specification (JECFA, 
2002d). 
0.061  
No safety concern a) 
 
 
08.067 1,2,5,6-Tetrahydrocuminic 
acid 
OH
O 3731 
 
71298-42-5 
976 
JECFA specification (JECFA, 
2002d). 
0.012  
No safety concern a) 
 
 
09.028 2-Cyclohexylethyl acetate O
O
2348 
218 
21722-83-8 
964 
JECFA specification (JECFA, 
2002d). 
0.97  
No safety concern a) 
Deleted b) 
 
09.289 alpha-Campholene acetate 
O
O
3657 
 
36789-59-0 
969 
JECFA specification (JECFA, 
2002d). 
0.061  
No safety concern a) 
 
JECFA evaluated 
campholene acetate 
(CASrn as in Register). 
CASrn in Register refers 
to the (S)-enantiomer. 
09.488 Ethyl cyclohexanepropionate 
O
O 2431 
2095 
10094-36-7 
966 
JECFA specification (JECFA, 
2002d). 
0.12  
No safety concern a) 
Deleted b) 
 
09.534 Ethyl cyclohexanecarboxylate 
O
O 3544 
11916 
3289-28-9 
963 
JECFA specification (JECFA, 
2002d). 
0.24  
No safety concern a) 
 
 
09.536 Methyl 
cyclohexanecarboxylate 
O
O 3568 
11920 
4630-82-4 
962 
JECFA specification (JECFA, 
2002d). 
0.073  
No safety concern a) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(g/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
09.615 p-Menth-1-en-9-yl acetate 
O
O
3566 
10748 
28839-13-6 
972 
JECFA specification (JECFA, 
2002d). 
0.85  
No safety concern a) 
 
 
1) EU MSDI: Amount added to food as flavouring substance in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Category 1: Considered safe in use, Category 2: Temporarily considered safe in use, Category 3: Insufficient data to provide assurance of safety in use, Category 4: Not acceptable due to evidence of toxicity. 
3) No safety concern at estimated levels of intake. 
4) Category A: Flavouring substance, which may be used in foodstuffs, Category B: Flavouring substance which can be used provisionally in foodstuffs. 
a) (JECFA, 2002c). 
b) (CoE, 1992). 
ND)  No intake data reported. 
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ANNEX I: PROCEDURE FOR THE SAFETY EVALUATION 
The approach for a safety evaluation of chemically defined flavouring substances as referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), named the "Procedure", is shown in schematic 
form in Figure I.1. The Procedure is based on the Opinion of the Scientific Committee on Food expressed on 
2 December 1999 (SCF, 1999a), which is derived from the evaluation Procedure developed by the Joint 
FAO/WHO Expert Committee on Food Additives at its 44th, 46th and 49th meetings (JECFA, 1995; JECFA, 
1996a; JECFA, 1997a; JECFA, 1999b). 
The Procedure is a stepwise approach that integrates information on intake from current uses, structure-
activity relationships, metabolism and, when needed, toxicity. One of the key elements in the Procedure is 
the subdivision of flavourings into three structural classes (I, II, III) for which thresholds of concern (human 
exposure thresholds) have been specified. Exposures below these thresholds are not considered to present a 
safety concern. 
Class I contains flavourings that have simple chemical structures and efficient modes of metabolism, which 
would suggest a low order of oral toxicity. Class II contains flavourings that have structural features that are 
less innocuous, but are not suggestive of toxicity. Class III comprises flavourings that have structural 
features that permit no strong initial presumption of safety, or may even suggest significant toxicity (Cramer 
et al., 1978). The thresholds of concern for these structural classes of 1800, 540 or 90 microgram/person/day, 
respectively, are derived from a large database containing data on subchronic and chronic animal studies 
(JECFA, 1996a). 
In Step 1 of the Procedure, the flavourings are assigned to one of the structural classes. The further steps 
address the following questions: 
 can the flavourings be predicted to be metabolised to innocuous products8 (Step 2)?  
 do their exposures exceed the threshold of concern for the structural class (Step A3 and B3)? 
 are the flavourings or their metabolites endogenous9 (Step A4)?  
 does a NOAEL exist on the flavourings or on structurally related substances (Step A5 and B4)? 
In addition to the data provided for the flavouring substances to be evaluated (candidate substances), 
toxicological background information available for compounds structurally related to the candidate 
substances is considered (supporting substances), in order to assure that these data are consistent with the 
results obtained after application of the Procedure.  
The Procedure is not to be applied to flavourings with existing unresolved problems of toxicity. Therefore, 
the right is reserved to use alternative approaches if data on specific flavourings warranted such actions. 
                                                     
 
8 “Innocuous metabolic products”: Products that are known or readily predicted to be harmless to humans at the 
estimated intakes of the flavouring agent” (JECFA, 1997a). 
 
9 “Endogenous substances”: Intermediary metabolites normally present in human tissues and fluids, whether free or 
conjugated; hormones and other substances with biochemical or physiological regulatory functions are not included 
(JECFA, 1997a). 
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Decision tree structural class 
Can the substance be predicted to be metabolised to innocuous products?
Procedure for Safety Evaluation of Chemically Defined Flavouring Substances 
Do the conditions of use result in an intake greater than the 
threshold of concern for the structural class?
Do the conditions of use result in an intake greater than the  
threshold of concern for the structural class? 
Data must be available on the  
substance or closely related  
substances to perform a safety 
evaluation
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is  high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
  Substance would not be    
expected to be of safety concern
Is the substance or are its metabolites endogenous?
Additional data required 
Step 1. 
Step 2. 
Step A3. 
Step A4. 
Step A5. 
Step B3. 
Step B4.
 Yes No
 Yes 
 No 
No
No
Yes
No
Yes
Yes
Yes
 No
Figure I.1 Procedure for Safety Evaluation of Chemically Defined Flavouring Substances
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ANNEX II: USE LEVELS / MTAMDI 
II.1 Normal and Maximum Use Levels 
For each of the 18 Food categories (Table II.1.1) in which the candidate substances are used, Flavour 
Industry reports a “normal use level” and a “maximum use level” (EC, 2000a). According to the Industry the 
”normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th 
percentile of reported usages (EFFA, 2002i). The normal and maximum use levels in different food 
categories have been extrapolated from figures derived from 12 model flavouring substances (EFFA, 2004e). 
Table II.1.1 Food categories according to Commission Regulation (EC) No 1565/2000 (EC, 2000a). 
Food category Description 
01.0 Dairy products, excluding products of category 02.0 
02.0 Fats and oils, and fat emulsions (type water-in-oil) 
03.0 Edible ices, including sherbet and sorbet 
04.1 Processed fruit 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds 
05.0 Confectionery 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding bakery 
07.0 Bakery wares 
08.0 Meat and meat products, including poultry and game 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  
10.0 Eggs and egg products 
11.0 Sweeteners, including honey 
12.0 Salts, spices, soups, sauces, salads, protein products, etc. 
13.0 Foodstuffs intended for particular nutritional uses 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts 
15.0 Ready-to-eat savouries 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in categories 01.0 - 15.0 
 
The “normal and maximum use levels” are provided by Industry for the candidate substances in the present 
flavouring group (Table II.1.2). 
Table II.1.2 Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.12Rev2 (EFFA, 
2003i; EFFA, 2004z; EFFA, 2007a; EFFA, 2012q; Flavour Industry, 2009i). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
02.134 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.186 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
05.157 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
05.182 - 
- 
- 
- 
0,01 
0,1 
0,00
5 
0,05 
- 
- 
0,00
5 
0,05 
- 
- 
0,00
6 
0,06 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
0,00
2 
0,02 
0 
0 
- 
- 
- 
- 
05.183 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
05.198 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
08.135 10 
30 
- 
- 
- 
- 
- 
- 
- 
- 
10 
40 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
10 
40 
- 
- 
- 
- 
10 
30 
10 
40 
- 
- 
10 
40 
09.342 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.670 7 5 10 7 - 10 5 10 2 2 - - 5 10 5 10 20 5 
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Table II.1.2 Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.12Rev2 (EFFA, 
2003i; EFFA, 2004z; EFFA, 2007a; EFFA, 2012q; Flavour Industry, 2009i). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
35 25 50 35 - 50 25 50 10 10 - - 25 50 25 50 100 25 
09.829 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
II.2 mTAMDI Calculations 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values is 
based on the approach used by SCF up to 1995 (SCF, 1995). The assumption is that a person may consume 
the amount of flavourable foods and beverages listed in Table II.2.1. These consumption estimates are then 
multiplied by the reported use levels in the different food categories and summed up.  
Table II.2.1 Estimated amount of flavourable foods, beverages, and exceptions assumed to be consumed per 
person per day (SCF, 1995). 
Class of product category Intake estimate (g/day) 
Beverages (non-alcoholic) 324.0 
Foods 133.4 
Exception a: Candy, confectionery 27.0 
Exception b: Condiments, seasonings 20.0 
Exception c: Alcoholic beverages 20.0 
Exception d: Soups, savouries 20.0 
Exception e: Others, e.g. chewing gum e.g. 2.0 (chewing gum) 
 
The mTAMDI calculations are based on the normal use levels reported by Industry. The seven food 
categories used in the SCF TAMDI approach (SCF, 1995) correspond to the 18 food categories as outlined in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a) and reported by the Flavour Industry in the 
following way (see Table II.2.2): 
 Beverages (SCF, 1995) correspond to food category 14.1 (EC, 2000a) 
 Foods (SCF, 1995) correspond to the food categories 1, 2, 3, 4.1, 4.2, 6, 7, 8, 9, 10, 13, and/or 16 
(EC, 2000a) 
 Exception a (SCF, 1995) corresponds to food category 5 and 11 (EC, 2000a) 
 Exception b (SCF, 1995) corresponds to food category 15 (EC, 2000a) 
 Exception c (SCF, 1995) corresponds to food category 14.2 (EC, 2000a) 
 Exception d (SCF, 1995) corresponds to food category 12 (EC, 2000a) 
 Exception e (SCF, 1995) corresponds to others, e.g. chewing gum. 
Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995). 
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 Food categories according to Commission Regulation 1565/2000 Distribution of the seven SCF food categories 
Key Food category Food Beverages Exceptions 
01.0 Dairy products, excluding products of category 02.0 Food   
02.0 Fats and oils, and fat emulsions (type water-in-oil) Food   
03.0 Edible ices, including sherbet and sorbet Food   
04.1 Processed fruit Food   
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), 
and nuts & seeds 
Food   
05.0 Confectionery   Exception a 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & 
legumes, excluding bakery 
Food   
07.0 Bakery wares Food   
08.0 Meat and meat products, including poultry and game Food   
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  Food   
10.0 Eggs and egg products Food   
11.0 Sweeteners, including honey   Exception a 
12.0 Salts, spices, soups, sauces, salads, protein products, etc.    Exception d 
13.0 Foodstuffs intended for particular nutritional uses Food   
14.1 Non-alcoholic ("soft") beverages, excl. dairy products  Beverages  
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts   Exception c 
15.0 Ready-to-eat savouries   Exception b 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be 
placed in categories 01.0 - 15.0 
Food   
 
The mTAMDI values (see Table II.2.3) are presented for the 10 flavouring substances in the present 
flavouring group, for which Industry has provided use and use levels (EFFA, 2003i; EFFA, 2004z; EFFA, 
2007a; EFFA, 2012q; Flavour Industry, 2009i). The mTAMDI values are only given for the highest reported 
normal use levels. 
TableII.2.3 Estimated intakes based on the mTAMDI approach. 
FL-no EU Register name mTAMDI 
(g/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
02.134 2-Cyclohexylethan-1-ol 3900 Class I 1800 
02.186 Myrtanol 3900 Class I 1800 
05.157 Isocyclocitral 1600 Class I 1800 
05.182 2,6,6-Trimethylcyclohex-2-ene-1-carboxaldehyde 2.1 Class I 1800 
05.183 4-(2,6,6-Trimethylcyclohexenyl)-2-methylbutanal 1600 Class I 1800 
05.198 alpha-Methyl ional 1600 Class I 1800 
08.135 4-(2,2,3-Trimethylcyclopentyl)butanoic acid 5000 Class I 1800 
09.342 Cyclogeranyl acetate 3900 Class I 1800 
09.670 Myrtanyl acetate 3900 Class I 1800 
09.829 Ethyl cyclohexyl acetate 3900 Class I 1800 
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ANNEX III: METABOLISM 
III.1. Introduction 
The 10 candidate flavouring substances in this group evaluation are 2-cyclohexylethan-1-ol [FL-no: 02.134], 
myrtanol and its acetate [FL-no: 02.186 and 09.670, respectively], four aldehydes, isocyclocitral [FL-no: 
05.157], 2,6,6-trimethylcyclohex-2-ene-1-carboxaldehyde [FL-no: 05.182], 4-(2,6,6-trimethylcyclohexenyl)-
2-methylbutanal [FL-no: 05.183] and alpha-methyl ional [FL-no: 05.198], one acid, 4-(2,2,3-
trimethylcyclopentyl)butanoic acid [FL-no: 08.135] and ethyl cyclohexyl acetate [FL-no: 09.829] as well as 
the acetate of cyclogeraniol [FL-no: 09.342]. For none of these candidate substances, absorption, 
distribution, metabolism or elimination studies were available. The assessment of the toxicokinetic properties 
of this group of substances relies therefore on general knowledge about biotransformation and data for 
representatives of a group of 15 structurally related (supporting) substances, which have been evaluated 
during the 59th meeting of the JECFA. "Safety evaluations of groups of related flavouring agents: Alicyclic 
primary alcohols, aldehydes, acids, and related esters" (JECFA, 2003a).  
III.2. Absorption, Distribution, Metabolism and Elimination 
III.2.1 Ester hydrolysis 
 
Two of the candidate substances in this Flavouring Group Evaluation are esters of alicyclic alcohols and 
acetic acid, cyclogeranyl acetate [FL-no: 09.342] and myrtanyl acetate [FL-no: 09.670], and one is an ester 
of alicyclic carboxylic acid and ethanol, ethyl cyclohexyl acetate [FL-no: 09.829], which can be expected to 
be subject to hydrolysis.  
Ester hydrolysis is catalysed by classes of enzymes known as carboxyl-esterases (Graffner-Nordberg et al., 
1998), the most important of which are the B-esterases. Although these enzymes are present in most 
mammalian tissues, they predominate in the liver (Heymann, 1980; Graffner-Nordberg et al., 1998). The 
substrate specificity of B-carboxylesterase isoenzymes has been correlated with the structure of the alcohol 
and acid components (Heymann, 1980). The aliphatic esters hydrolyse rapidly in liver homogenate, 
simulated pancreatic fluid, simulated gastric fluid and preparations of intestinal mucosa in vitro (Junge and 
Heymann, 1979; Leegwater and van Straten, 1974a; Leegwater and van Straten, 1974b; Longland et al., 
1977; Grundschober, 1977; Graffner-Nordberg et al., 1998). Results of in vitro studies indicate that the 
affinity of the esterases for their substrates increases as the length of the ester increases and that the rate of 
hydrolyses of the straight-chain esters is approximately 100 times faster than the rate of hydrolysis of the 
branched-chain esters (Arndt and Krisch, 1973; Butterworth et al., 1975a; Junge and Heymann, 1979). 
Cyclohexanecarboxylate methyl ester and cyclohexanecarboxylate ethyl ester were incubated separately with 
50 ml simulated gastric fluid at 37° C, for six hours. Results showed approximately 20 % hydrolysis of each 
ester in the gastric fluid system. After a five-hour incubation in simulated intestinal fluid, approximately 40 
and 50 % of cyclohexanecarboxylate methyl- and ethyl esters were hydrolysed, respectively (Moran and 
Tyburcy, 1979). In an in vitro hydrolysis study, 100 % of cyclohexanepropionate ethyl ester was hydrolysed 
after two-hours of incubation in 5 % pancreatin (Grundschober, 1977; Leegwater and Straten, 1974a).  
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The in vitro hydrolysis of the structurally related ester p-1-(7)8-menthadien-2-yl acetate10 was investigated in 
rat liver homogenate. After incubation of this substance in homogenate at 37° C for 15, 30 and 60 minutes, 
complete (100 %) hydrolysis was observed after 60 minutes, with 92 % hydrolysis occurring within the first 
15 minutes (Salzer, 1998).  
These data indicate that after oral exposure, the three candidate esters in this group of flavouring substances 
[FL-no: 09.342, 09.670 and 09.829] will be hydrolysed either prior to absorption by enzymes in the gastro-
intestinal tract or by esterases in the liver after absorption to yield their component alcohols and carboxylic 
acids. The component acid (acetic acid) from two of these esters [FL-no: 09.342 and 09.670] has been 
evaluated previously (e.g. FGE.01 or FGE.02) and the component ethanol from [FL-no: 09.829] (the JECFA 
had concluded that ethanol posed no safety concern at its current level of intake when ethyl esters are used as 
flavouring agents (JECFA, 1997a)) will not be further discussed in this FGE. 
 
III.2.2 Absorption, Distribution and Excretion 
 
For the candidate substances, data on absorption, distribution and excretion are not available. Some data are 
available on the sodium salt of the supporting substance cyclohexanecarboxylic acid [FL-no: 08.060]10 and 
on the related substance perillyl alcohol10.  
 
Cyclohexanecarboxylic acid 
Cyclohexanecarboxylate sodium salt, with a 14C-labelled ring was orally administered to male Wistar albino 
rats at a dose of 100 mg/kg bw. Results showed that > 98 % of the original dose was excreted as urinary 
metabolites within seven hours. Less than 1 % was excreted via the faeces or expired air (Brewster et al., 
1977b).  
Cyclohexanecarboxylic acid and 1-methyl-1-cyclohexanecarboxylate were studied in bile-duct- and urinary 
tract-cannulated rats. Female Sprague-Dawley rats (four rats per compound) were administered via 
intravenous infusion a 0.52 mmol/kg bw bolus dose of cyclohexanecarboxylic acid (66 mg/kg bw) or 1-
methyl-1-cyclohexanecarboxylate (73 mg/kg bw), followed by a 0.3 ml saline flush for each rat. Hardly any 
parent substance was excreted into urine or bile. Biliary excretion of base-labile (presumably glucuronide) 
conjugates accounted for approximately 5 and 59 %, and urinary excretion accounted for 12 and 25 % of the 
systemic elimination of cyclohexanecarboxylate and 1-methyl-1-cyclohexanecarboxylate, respectively. The 
authors concluded that enterohepatic circulation occurs with 1-methyl-1-cyclohexanecarboxylic acid but not 
with cyclohexanecarboxylic acid itself (Liu et al., 1992). 
 
Perillyl alcohol 
The kinetics of p-mentha-1,8-dien-7-ol (i.e. perillyl alcohol) have been studied in rats, dogs and in humans. 
This substance is most closely related to p-mentha-1,8(10)-dien-9-ol and its acetate [FL-no: 02.122 and 
09.809, respectively] (Subgroup 2.1 of FGE.19 (EFSA, 2008b)).  
                                                     
 
10 
O O
OHO OH
p-1-(7)8-menthadien-2-yl acetate cyclohexanecarboxylic acid perillyl alcohol  
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Within four hours after a single dose of 1000 mg perillyl alcohol/kg bw, administered to female Wistar-Furth 
rats via gavage, major plasma metabolites were identified as oxidised metabolites of perillyl alcohol (perillic 
acid and dihydroperillic acid). No trace of perillyl alcohol was detected in the plasma at any time point, 
including 15-minutes post-gavage (Haag and Gould, 1994). 
Two beagle dogs (male and female) administered 250 mg perillyl alcohol/kg bw by gavage exhibited peak 
plasma levels of oxidised metabolites of perillyl alcohol (i.e. perillic acid and dihydroperillic acid) at 1 and 5 
hours post-administration, respectively. Analysis of blood specimens collected before dosing and at 19 time 
points ranging from 10 minutes to 48 hours after dosing, indicated the presence of the oxidised metabolites 
10-minutes post-administration. The parent substance, perillyl alcohol, was undetectable in the plasma 
(Phillips et al., 1995). 
Patients with various advanced malignancies were treated orally with doses of 800, 1600 or 2400 mg perillyl 
alcohol/m2/dose (equivalent to ca. 32, 64 or 96 mg/kg bw/dose, assuming a body mass index of 25 kg/m2). 
On the first day only a single dose was given, but thereafter the treatment was continued for four weeks but 
on a three doses per day basis. Kinetics were studied after the first and last dose. The parent drug was not 
detected in the plasma. Peak plasma levels for the two main metabolites of perillyl alcohol occurred at 1.5 - 
3.5 hours (perillic acid) and 3 - 5 hours (dihydroperillic acid) post-administration. Plasma elimination half-
lives of the two metabolites studied were 1 - 6 hours and 2 - 3 hours, respectively. Repeated dosing did not 
affect Cmaxs or AUCs for these two metabolites, but there was a clear “levelling of” of Cmaxs and AUCs for the 
metabolites when the dose increased from 1600 to 2400 mg/m2. From the patients treated with 2400 
mg/m2/dose, urinary metabolites were collected up to 24 hours after the first dose or up to 6 hours after the 
last dose. In both cases ~ 1 % of the dose was collected as unchanged perillic alcohol. Approximately 10 % 
of the dose was recovered, less than 10 % of which was unchanged parent substance (Ripple et al., 1998). 
As part of a phase I dose-escalation trial, perillyl alcohol was administered p.o. at 800, 1200, or 1600 mg/ 
m2/dose (equivalent to ca. 32, 48, or 64 mg/kg bw/dose, assuming a body mass index of 25 kg/m2) to sixteen 
patients with advanced refractory malignancies on a four times per day continuous basis for four weeks to 
characterise its kinetic profile, maximum tolerated dose, toxicity and antitumour activity. There appeared to 
be a dose-dependent increase in the plasma levels of the two main metabolites, perillic acid and 
dihydroperillic acid (see below). There was a trend toward decreasing metabolite levels on day 29 as 
compared to days 1 and 2. Peak metabolite levels were seen 1 - 3 hours post-administration and metabolite 
half-lives were about 2 hours. No indication of dose-related effects on the kinetics was obtained. 
Approximately 9 % of the total dose was recovered in the urine in the first 24 hours. Only ~ 0.1 % of the 
dose was recovered as parent substance (Ripple et al., 2000). 
From the above mentioned studies it can be concluded that in humans, dogs and rats orally administered 
perillyl alcohol is rapidly absorbed and metabolised after ingestion. 
 
III.2.3 Biotransformation 
 
Cyclohexyl Derivatives 
Metabolism studies conducted on representative flavouring agents indicate that these substances are 
metabolised primarily by oxidation of the primary alcohol or aldehyde function to yield the corresponding 
carboxylic acid or oxidation of the alkyl ring substituents to yield polyoxygenated polar metabolites that are 
readily excreted. 
The metabolic options available to alicyclic substances increase as the number and types of functional groups 
and ring substituents in the molecule increase. If a primary alcohol, aldehyde or carboxylic acid function is 
present on an alkyl side-chain of the ring, the substance may undergo beta-oxidation at the side chain. For 
the present group of flavouring substances, this seems in particular important for [FL-no: 05.183 and 
08.135], because these are the only ones with a side chain which might be shortened by beta-oxidation. If the 
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number of carbons present in the side-chain is odd, beta-oxidative cleavage cannot continue beyond the point 
of side-chain attachment but the resulting carboxylic acids may be conjugated with glucuronic acid or 
glycine (Bernhard and Caflisch-Weill, 1945; Brewster et al., 1977b; Williams, 1959a).  
 
Terpenoid Primary Alcohols and Aldehydes 
An indication about the metabolic fate of the monocyclic and bicyclic terpenoid aldehydes and alcohols (e.g. 
candidate substances myrtanol [FL-no: 02.186], isocyclocitral [FL-no: 05.157], 2,6,6-trimethylcyclohex-2-
ene-1-carboxaldehyde [FL-no: 05.182],  cyclogeranyl acetate [FL-no: 09.342] and myrtanyl acetate [FL-no: 
09.670] and supporting substances) can be obtained from the biotransformations of representative supporting 
substance aldehydes p-mentha-1,8-dien-7-al (i.e. perillaldehyde) and 2-formyl-6,6-
dimethylbicyclo[3.1.1]hept-2-ene (i.e. myrtenal), which have been described below. In addition, for the 
metabolism of the flavouring substances isocyclocitral [FL-no: 05.157], 2,6,6-trimethylcyclohex-2-ene-1-
carboxaldehyde [FL-no: 05.182], 4-(2,6,6-trimethylcyclohexenyl)-2-methylbutanal [FL-no: 05.183], alpha-
methyl ional [FL-no: 05.198] and cyclogeranyl acetate [FL-no: 09.342], in which multiple and cycloalkene 
methyl side-chains occur, the metabolism of isophorone (3,5,5-trimethylcylohex-2-ene-1-one [FL-no: 
07.126]11, alpha-ionone [FL-no: 07.007]11 and beta-ionone and [FL-no: 07.008]11might be used as an 
example. 
 
Isophorone 
When isophorone11 was given to rabbits in an oral dose of 1 g/kg bw, glucuronic acid conjugates could be 
detected in the urine, and after treatment of the urine with hydrochloric acid, the metabolite 5,5-dimethyl-
cyclohex-1-ene-3-one-1-carboxylic acid was found. This shows that for these substances, oxidation of the 
methyl side chain is a possible metabolic pathway, which, probably via alcohol and aldehyde intermediates, 
leads to formation of free or conjugated carboxylic acid end products (Truhaut et al., 1970). 
 
Alpha- and Beta-ionone 
The candidate substances 2,6,6-trimethylcyclohex-2-ene-1-carboxaldehyde [FL-no: 05.182], alpha-methyl 
ional [FL-no: 05.198] and cyclogeranyl acetate [FL-no: 09.342] are structurally related to alpha-ionone [FL-
no: 07.007]11 and 4-(2,6,6-trimethylcyclohexenyl)-2-methylbutanal [FL-no: 05.183] is structurally related to 
beta-ionone [FL-no: 07.008]11. Available metabolic data on these two ionones indicate that they may 
undergo allylic ring hydroxylation and possible further oxidation to keto groups. These reactions result in the 
formation of polar metabolites, which are excreted in the urine unchanged or conjugated with glucuronic 
acid (JECFA, 1999a). It is anticipated that the four candidate substances [FL-no: 05.182, 05.183, 05.198 and 
09.342], at least partially, may form similar polar metabolites and be excreted with the urine.  
 
Perillyl Alcohol and Perillaldehyde 
The metabolism of perillyl alcohol, perillaldehyde and perillic acid was determined after intravenous 
injection in male Wistar rats and in exposed isolated rat hepatocytes. Although perillaldehyde can react 
spontaneously with glutathione, no indication of the formation of GSH conjugates was found either in vivo 
or in hepatocytes. After dosing with perillaldehyde, about 50 % of the doses were recovered as glucuronides 
in bile and urine. From perillic acid only the acyl glucuronide was generated, whereas perillyl alcohol and 
perillaldehyde formed both acyl and ether glucuronides. The results, together with those of studies in which 
alcohol dehydrogenase or aldehyde dehydrogenase were inhibited, indicate that perillaldehyde is a major 
intermediary metabolite of perillyl alcohol in the rat in vivo and in rat hepatocytes in vitro (Boon et al., 
2000). 
To six male rabbits, p-mentha-1,8-dien-7-al (perillaldehyde) was administered orally at a dose level of 2000 
mg per animal. Urine was collected for three consecutive days, pooled and treated with glucuronidase/aryl 
sulphatase. The neutral urinary fraction contained two metabolites comprising 7 % of the totally 
administered amount of parent substance. These metabolites were identified as (-)-perillyl alcohol and (-)-
cis-shisool (i.e. para-menth-8-en-7-ol), representing 46 and 39 % of the neutral metabolites, respectively. 
The acidic fraction comprised 39 % of the administered amount of perillaldehyde and the two major 
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metabolites in this fraction were perillic acid, which represented 57 % of the acidic urinary metabolites and 
p-isopropylbenzoic acid (amount not specified). These results indicate that perillaldehyde was oxidised to p-
mentha-1,8-dien-7-carboxylic acid (i.e. perillic acid). Aromatisation of the cyclohexene ring and reduction of 
the isopropenyl double bond converted perillic acid in part to p-isopropylbenzoic acid. To a lesser extent, p-
mentha-1,8-dien-7-al was reduced to perillyl alcohol, which can be selectively hydrogenated to yield p-
mentha-8-en-7-ol (see Figure III.1) (Ishida et al., 1989b). Only a fairly low part of the administered dose was 
recovered. Other metabolites were not mentioned. 
 
O
OHO OHO
OH OH
Perillaldehyde
Perillic acid p-isopropenyl benzoic acid
major route
minor route
Perillyl alcohol p-menth-8-en-7-ol  
Figure III.1 Metabolism of perillaldehyde in rabbits 
Female Wistar-Furth rats were given a single oral dose of 100 mg perillyl alcohol/kg bw by gavage or were 
given a diet of 2 % perillyl alcohol for a period of 3, 5 or 10 weeks (nominally approximately 1.5 g/kg 
bw/day). Perillic acid and dihydroperillic acid were detected as major plasma metabolites and perillic acid 
methyl ester and dihydroperillic acid methyl ester were identified as minor metabolites. The authors 
concluded that the methyl esters were artifacts formed during processing of urine. Unchanged perillyl 
alcohol was not detected after the gavage dose, not even at 15 minutes post gavage, nor after sub-chronic 
feeding. These results indicate that perillyl alcohol is rapidly absorbed from the gastrointestinal tract and 
metabolised. The presence of dihydroperillic acid indicates that the endocyclic double bond was 
hydrogenated. After acute exposure the ratio perillic acid / dihydroperillic acid amounted to > 10, while after 
3 - 10 weeks of exposure via the diet this ratio had dropped to 2 - 3 (Haag and Gould, 1994).  
An in vivo study conducted in male Wistar rats confirmed that the oxidation of perillyl alcohol to perillic 
acid involved perillaldehyde as an intermediate. Rats were administered intravenously perillyl alcohol, 
perillaldehyde or perillic acid at a dose of 80 micromol/kg bw (approximately 12.2, 12.0 or 13.3 mg/kg bw, 
respectively). Urine and bile were collected for two consecutive hours post administration. In all cases, the 
glucuronic acid conjugate of perillic acid was the predominant metabolite detected in the urine (10 % of the 
dose) and bile (46 % of the dose). The glucuronic acid conjugate of perillyl alcohol was also a major biliary 
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metabolite following the intravenous administration of perillyl alcohol (5 %), while urinary excretion of this 
conjugate amounted to 1 % of the dose. Based on the results, the authors concluded that within two hours, 
approximately 56 % of the original dose had been oxidised to perillic acid through perillaldehyde, and 
eventually excretion as a glucuronic acid conjugate (Boon et al., 2000).  
Patients with various advanced malignancies were treated orally with one dose, followed by three daily doses 
on the following 29 days, of 2400 mg perillyl alcohol/m2 (equivalent to ca. 96 mg/kg bw, assuming a body 
mass index of 25 kg/m2). Urinary metabolites were collected up to 24 hours after the first dose or up to 6 
hours after the last dose. In both cases ~ 1 % of the dose was collected as unchanged perillic alcohol. Two 
metabolites were found, which comprised approximately 9 % of the dose of which ~ 90 % perillic acid and 
10 % dihydroperillic acid. Other metabolites were not monitored (Ripple et al., 1998). 
As part of a phase I dose-escalation trial, perillyl alcohol was administered p.o. at 1200 or 1600 mg/ m2/dose 
(equivalent to ca. 48 or 64 mg/kg bw/dose, assuming a body mass index of 25 kg/m2) to sixteen patients with 
advanced refractory malignancies on a four times per day continuous basis for four weeks. Approximately 9 
% of the total dose was recovered in the urine in the first 24 hours on the first day of treatment and slightly 
more was recovered on day 15 or 29 during 6 hours post dosing. At all time points, approximately 80 to 85 
% of the recovered metabolites were perillic acid and 10 to 17 % was dihydroperillic acid. Only about 1 % of 
the dose was recovered as parent substance. Other metabolites were not monitored (Ripple et al., 2000). 
 
Myrtenal 
Six male rabbits received an oral dose of 2000 mg of 2-formyl-6,6-dimethyl-bicyclo[3.1.1]hept-2-ene (= (-)-
myrtenal) per animal. In the urine of these animals, myrtenol, dihydromyrtenol, myrtenic acid and perillic 
acid could be detected. Myrtenol and dihydromyrtenol comprised together 99 % of the neutral metabolite 
fraction (5 % of the dose). Myrtenic acid represented 76 % of the acid metabolites detected in the urine, but 
the amount of perillic acid was not specified. The total acidic fraction of urinary metabolites comprised 24 % 
of the dose. These results indicate that myrtenal can be metabolised to the corresponding carboxylic acid 
(myrtenic acid). The presence of perillic acid indicates some cleavage of the strained bicyclic ring. To a 
lesser extent, the aldehyde can either be reduced to myrtenol, which may be conjugated with glucuronic acid 
and excreted or it may undergo hydrogenation of the double bond to yield dihydromyrtenol (myrtanol), see 
Figure III.2, which is one of the candidate substances [FL-no: 02.186], shown to be the major neutral 
metabolite and excreted unchanged with the urine (Ishida et al., 1989b). Urine was collected during 3 days 
post dosing. Only a fairly low part of the administered dose was recovered. Other metabolites were not 
mentioned. 
Humans exposed to sawmill dust excreted in the urine the glucuronic acid conjugate of myrtenol (2-
hydroxymethyl-6,6-dimethyl-bicyclo[3.1.1]hept-2-ene [FL-no: 02.091] (the component alcohol in candidate 
flavouring substances [FL-no: 09.899 and 09.900])) (Subgroup 2.2 of FGE.19 (EFSA, 2008b)) (Eriksson and 
Levin, 1990). The myrtenol was not detected in the sawdust (Eriksson and Levin, 1990), but could have 
originated from side-chain oxidation of alpha-pinene (= 2,6,6-trimethyl-bicyclo[3.1.1]hept-2-ene [FL-no: 
01.004] (FGE, 78Rev1 (EFSA, 2011j)) (Ishida et al., 1981). 
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Figure III.2 Metabolism of myrtenal in rabbits 
In summary, in mammals, monocyclic or bicyclic terpenoid primary alcohols (e.g. cyclogeraniol [from FL-
no: 09.342] and myrtanol [FL-no: 02.186] (and from [FL-no: 09.670]), and the structurally related substance 
perillyl alcohol) are generally oxidised to the corresponding carboxylic acid, conjugated with glucuronic acid 
and are excreted as urinary metabolites. The same is true for the monocyclic aldehydes (candidate substances 
isocyclocitral [FL-no: 05.157], 2,6,6-trimethylcyclohex-2-ene-1-carboxaldehyde [FL-no: 05.182] and  4-
(2,6,6-trimethylcyclohexenyl)-2-methylbutanal [FL-no: 05.183]) and structurally related substances 
perillaldehyde and isophorone), which contain alkyl ring substituents. In a minor pathway, the aldehyde may 
be reduced to the alcohol and excreted as the glucuronide (Ishida et al., 1989b; Haag and Gould, 1994). If an 
endocyclic double bond is present, reduction of this double bond may occur 
III.3. Summary and Conclusions 
The 10 candidate substances in this group evaluation contain a monocyclic or bicyclic terpenoid moiety, all 
with a primary oxygenated substituent. The evaluation of the metabolism and other aspects of kinetics of the 
candidate substances in this Flavouring Group Evaluation depend entirely on information for structurally 
related substances and on general knowledge on biochemistry and biotransformation of xenobiotic 
substances. 
It can be expected that the esters in this group will be hydrolysed to yield their component alcohols and 
carboxylic acids. It can also be expected that these hydrolysis products may be absorbed, and that any 
remaining unhydrolysed flavouring substance after absorption will be hydrolysed in the liver. Gastro-
intestinal absorption can also be expected for the free alcohol and the free aldehyde in this group. 
The metabolic fate of the component alcohols, the free candidate alcohols and the four aldehydes in this 
Flavouring Group is not completely elucidated. It can be expected that oxidation of the hydroxyl group or 
aldehyde group will result in the formation of carboxylic acids which can be conjugated and excreted. 
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Alternatively, the component or free alcohols in this group may be conjugated to glucuronide or sulphate 
without any further oxidation. Further, the cyclohexene derivatives may undergo allylic hydroxylation of the 
ring and then possible oxidation to keto groups or conjugation with glucuronic acid. These polar metabolites 
are expected to be excreted in the urine. 
Following absorption, the acids can be expected to be metabolised further via beta-oxidation (if applicable). 
Alternatively, they can be expected to be conjugated and excreted via the urine. 
Neither the chemical structures of the candidate substances in this group nor the metabolic data available 
suggest that reactive metabolites could be generated. Hence, it may be expected that the candidate substances 
in this flavouring group are absorbed and metabolised to innocuous products, which are excreted. 
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ANNEX IV: TOXICITY 
Oral acute toxicity data are available for three candidate substances of the present Flavouring Group Evaluation, and for nine supporting substances evaluated 
by the JECFA at the 59th meeting (JECFA, 2003a). The supporting substances are listed in brackets. 
TABLE IV.1: ACUTE TOXICITY 
Chemical Name [FL-no] Species  Sex  Route  LD50 
(mg/kg bw)  
Reference  Comments 
(Cyclohexanecarboxylic acid [08.060]) Rat  M, F Gavage 3265 (Moran et al., 1980) Study acceptable but number of dosage groups, and thus 
number of animals tested, has not been referred.  
(Methyl cyclohexanecarboxylate [09.536]) Rat  M, F  Gavage  3881  (Moran et al., 1980) Study acceptable but number of dosage groups has not been 
referred. 
(Ethyl cyclohexanecarboxylate [09.534]) Rat  M, F  Gavage  3962  (Moran et al., 1980) Study acceptable but number of dosage groups has not been 
referred. 
(Cyclohexaneethyl acetate [09.028]) Rat  NR  Oral  3200  (Wohl, 1974c) Not adequate LD50 study. 
 Rat  NR Oral 2190 (Moreno, 1978h) The study is considered valid. 
(2,2,3-Trimethylcyclopent-3-en-1-yl acetaldehyde [05.119]) Rat  NR  Oral  4300  (BIBRA, 1976) The LD50 value cited is deduced according to Litchfield & 
Wilcoxon, 1949. Another LD50 value is also cited in the 
BIBRA study, 3900 mg/kg, deduced according to Weill, 
1952.  
 Rat NR Oral 4100 (Moreno, 1978h) Study acceptable. Substance name is given as ‘aldehyde 
campholenique’.  
(Campholene acetate [09.289]) Rat  M, F  Gavage  M: 4640 – 
5270  
F: 3000  
(Piccirillo et al., 1979) The study is considered valid. 
(alpha-Campholenic alcohol [02.114]) Rat  NR 
 
 
 
Gavage  1000 – 2000  (Levenstein, 1982a) Study is inadequate for determination of LD50.  
Also substance name is only given as code.  
(1,2,5,6-Tetrahydrocuminic acid [08.067]) Rat  NR  Gavage  > 2500  (Levenstein, 1981a) Study inadequate for derivation of LD50. 
Also only code name given for substance. 
4-(2,6,6-Trimethylcyclohexenyl)-2-methylbutanal [05.183] Rat  NR  Oral  > 5000  (Moreno, 1977l) Study inadequate for derivation of LD50.  
Also substance name given as ‘cetonal’. It has not been 
possible to confirm that this is the same substance.  
(10-Hydroxymethylene-2-pinene [02.141]) Rat NR 
 
 
 
Oral 890  (Moreno, 1977u) Study acceptable, but substance name given as Nopol. It has 
not been possible to confirm that this is the same substance. 
2-Cyclohexylethan-1-ol [02.134] Rat NR Oral 0.94 (Wohl, 1974h)  
Isocyclocitral [05.157] Rat NR Oral 4.5 ml/kg bw (Levenstein, 1973f)  
NR = Not reported.   
M = Male; F = Female. 
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TABLE IV.2: SUBACUTE / SUBCHRONIC / CHRONIC / CARCINOGENICITY STUDIES 
Chemical Name [FL-no] Species; Sex 
No./Group 
Route Dose levels Duration NOAEL 
(mg/kg bw/day) 
Reference Comments 
(2,2,3-Trimethylcyclopent-3-en-1-
yl)acetaldehyde [05.119]) 
Rat; M, F 
8 
Gavage  12  mg/kg bw/day 90 12 (BIBRA, 1976) Single dose study. 
M = Male; F = Female. 
 
TABLE IV.3: DEVELOPMENTAL AND REPRODUCTIVE TOXICITY STUDIES 
No developmental and reproductive toxicity data are available for the candidate substances of the present flavouring group evaluation from chemical group 7 
or for the supporting substances evaluated by the JECFA at the 59th meeting (JECFA, 2003a).  
 
 
TABLE IV.4: GENOTOXICITY (IN VITRO) 
No in vitro mutagenicity/genotoxicity data are available for the candidate substances of the present flavouring group evaluation from chemical group 7 or for 
the supporting substances evaluated by the JECFA at the 59th meeting (JECFA, 2003a).  
 
TABLE IV.5: GENOTOXICITY (IN VIVO) 
No in vivo mutagenicity/genotoxicity data are available for the candidate substances of the present flavouring group evaluation from chemical group 7 or for 
the supporting substances evaluated by the JECFA at the 59th meeting (JECFA, 2003a).  
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ABBREVIATIONS 
ADI  Acceptable Daily Intake 
AUC  Area Under Curve 
BW  Body Weight 
CAS  Chemical Abstract Service 
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CHO  Chinese hamster ovary (cells) 
CoE  Council of Europe 
DNA  Deoxyribonucleic acid 
EC  European Commission 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
ID   Identity 
IOFI  International Organization of the Flavour Industry 
IR   Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
LD50  Lethal Dose, 50 %; Median lethal dose 
MS  Mass spectrometry 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NAD  Nicotinamide Adenine Dinucleotide  
NADP  Nicotinamide Adenine Dinucleotide Phosphate 
No  Number 
NOAEL No Observed Adverse Effect Level 
NOEL  No Observed Effect Level 
NTP  National Toxicology Program 
PO  Per Oral 
SCE  Sister Chromatid Exchange 
SCF  Scientific Committee on Food 
SMART  Somatic Mutation and Recombination Test  
TAMDI Theoretical Added Maximum Daily Intake 
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UDS  Unscheduled DNA Synthesis  
WHO  World Health Organisation 
 
 
